Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-04-001531
Filing Date
2004-01-22
Accepted
2004-01-22 06:42:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 a2127112z424b5.htm 424B5 341437
3 G472136.JPG g472136.jpg GRAPHIC 4949
4 G579302.JPG g579302.jpg GRAPHIC 5198
  Complete submission text file 0001047469-04-001531.txt   353315
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-109340 | Film No.: 04536500
SIC: 2836 Biological Products, (No Diagnostic Substances)